Medication-Induced Gastroparesis: A Case Report
暂无分享,去创建一个
[1] C. Malbert,et al. Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady‐state concentrations , 2020, Diabetes, obesity & metabolism.
[2] N. Talley,et al. Epidemiology and Pathophysiology of Gastroparesis. , 2019, Gastrointestinal endoscopy clinics of North America.
[3] Q. Cai,et al. Diabetic Gastroparesis and Nondiabetic Gastroparesis. , 2019, Gastrointestinal endoscopy clinics of North America.
[4] T. Abell,et al. Gastroparesis Updates on Pathogenesis and Management , 2017, Gut and liver.
[5] B. Sloth,et al. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults , 2013, International Journal of Obesity.
[6] M. Horowitz,et al. Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones , 2013, Diabetes Care.
[7] Karen L Jones,et al. Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia. , 2010, The Journal of clinical endocrinology and metabolism.
[8] Hye-Kyung Jung,et al. Incidence , Prevalence , and Outcomes of Patients With Gastroparesis n Olmsted County , Minnesota , From 1996 to 2006 , 2022 .
[9] Michael Horowitz,et al. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses. , 2006, The Journal of clinical endocrinology and metabolism.